Connection
Katie Ryan to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Katie Ryan has written about Drug Resistance, Neoplasm.
|
|
Connection Strength |
|
|
|
|
|
0.158 |
|
|
|
-
Ryan KR, Giles F, Morgan GJ. Targeting both BET and CBP/EP300 proteins with the novel dual inhibitors NEO2734 and NEO1132 leads to anti-tumor activity in multiple myeloma. Eur J Haematol. 2021 Jan; 106(1):90-99.
Score: 0.158